RT Journal
A1 Shah B, Danoff A, Radford MJ, Rolnitzky L, Sedlis SP
T1 Periprocedural management of the patient with diabetes mellitus undergoing coronary angiography: Current practice
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 2012
FD October 22
VO 172
IS 19
SP 1514
OP 1516
DO 10.1001/archinternmed.2012.3630
UL http://dx.doi.org/10.1001/archinternmed.2012.3630
AB 
Despite advances in procedural technique and pharmacotherapy, patients with diabetes mellitus (DM) experience worse outcomes than patients without DM undergoing percutaneous coronary intervention (PCI).1 Periprocedural hyperglycemia is associated with adverse clinical outcomes in patients undergoing PCI,2- 5 and studies have suggested that treating periprocedural hyperglycemia may improve outcomes by attenuating glucose-mediated ischemic injury at the time of PCI.6- 7 Simple preventive strategies, such as continuing long-acting hypoglycemic medications, have not been evaluated, and there are no guidelines for periprocedural use of these medications.